Dr Tan Bee Kim
Academic Qualification
- Doctor of Philosophy, UNIVERSITY OF MALAYA, Malaysia
- Master of Science, UNIVERSITY OF LONDON, United Kingdom
- Bachelor of Pharmacy, UNIVERSITY OF MALAYA, Malaysia
Professional Qualification
No records found
Areas of Expertise
- Medical And Health Sciences, Pharmacy, Clinical Pharmacy
Research Interest
No records found
Publications
2024
- Effectiveness of mHealth apps on adherence and symptoms to oral anticancer medications. a systematic review and meta-analysis. (ISI-Indexed), Supportive Care in Cancer - Article in Journals
- Acceptance of Electronic Labeling for Medicinal Product Information Among Malaysian Hospital Patients: Cross-Sectional Study (ISI-Indexed), Journal of Medical Internet Research - Article in Journals
2022
- Effect of high-dose vitamin B multivatamin supplement on neural connectivity and oxidative metabolism assessed by MR Spectrosposcopy and Neurite Orientation Dispersion Density Imaging (NODDI) (SCOPUS-Indexed) - Article in Proceeding
- Pharmacy Graduate's Preparedness to Practice Pharmaceutical Care in Non-Communicable Diseases: A Qualitative Study of Stakeholders' Perspectives. - Article in Proceeding
- Effectiveness of Shared Decision Making on Adherence to Antidepressant among Patients with Major Depressive Disorder. A Systematic Review. - Article in Proceeding
- Pharmacy students' preparation to provide pharmaceutical care for patients with non-communicable diseases in six ASEAN countries: A qualitative study (ISI-Indexed), Currents in Pharmacy Teaching and Learning - Article in Journals
2021
- Exploring decision-making process in deciding antiepileptic drugs among epilepsy patients & healthcare professionals - Article in Proceeding
- Challenges in pharmacy education with limited resources during Covid-19: ASEAN perspective - Book Chapter
- Acceptability of pharmacist-led interventions to resolve drug-related problems in patients with chronic myeloid leukaemia (ISI-Indexed), Journal of Oncology Pharmacy Practice - Article in Journals
- Monitoring and improving adherence to tyrosine kinase inhibitors in patients with chronic myeloid leukemia: A systematic review. (ISI-Indexed), PATIENT PREFERENCE AND ADHERENCE - Article in Journals
2020
- Efficacy of a medication management service in improving adherence to tyrosine kinase inhibitors and clinical outcomes of patients with chronic myeloid leukemia (ISI-Indexed), Supportive Care in Cancer - Article in Journals
2019
- The 16th Malaysian Society of Hematology (MSH) Scientific Meeting - Article in Proceeding
2017
- PCNE working conference 2017 (ISI-Indexed) - Article in Proceeding
- Medication-related issues associated with adherence to long-term tyrosine kinase inhibitors for controlling chronic myeloid leukemia: a qualitative study. (ISI-Indexed), Patient Preference and Adherence - Article in Journals
2012
- Health beliefs and perception of breast cancer patients in relation to the usage of herbal medicines. - Article in Proceeding
2002
- Public usage of oral lecithin: to reduce plasma cholesterol. - Article in Proceeding
Research
- Epidemiology and Management of Dry Eye Disease in Community Pharmacies, Project Leader, 2023 to 2025, Private
- A study on framework of a new remote personalised oral anticancer medication self-management model for patients with haematological malignancies, Project Leader, 2023 to 2026, National
- Epidemiology and management of dry eye disease at community pharmacies, Project Leader, 2023 to 2024, National
- Acceptance towards e-Product Information (e-PI) among patients and healthcare professionals , Project Leader, 2023, National
- Readiness in Pharmacy Students Preparation to Provide Pharmaceutical Care for NCD patients in ASEAN Countries: a qualitative study, Co-researcher, 2020 to 2021, International
- Effect of high-dose-vitamin-B multivitamin supplement on neural connectivity and oxidative metabolism in healthy adults: A randomised, double-blind, placebo-controlled, phase II clinical trial , Co-researcher, 2019 to 2024, International
- An international field study for the reliability and validity of the Phase IV EORTC Quality of Life module for patients with Chronic Myeloid Leukemia (EORTC QLQ-CML24), Co-researcher, 2017 to 2020, International
- Impact of a pharmaceutical care model in the management of chronic myeloid leukaemia patients, Project Leader, 2015 to 2018, National
Awards and Stewardship
No records found
Paper Presented
- Case 3: Strategies to maximize quality of life for patients with CML in the later-line setting, Dr Bee Kim Tan (Pharmacist, moderator) & Mr Johan De Munter (Nurse specialist) (Course), INVITED SPEAKER , 08/05/2022 to 07/05/2023
- Multidisciplinary management of chronic myeloid leukaemia in the later-line setting: A holistic approach, Case 1: Third-line treatment options for an elderly patient with T315I mutation-positive CML and cardiovascular comorbidities. Prof. Dr med. Andreas Hocchaus (Haematologist, moderator) & Dr Bee Kim Tan (Pharmacist) (Course), INVITED SPEAKER , 09/05/2022 to 08/05/2023
- Facing the Future: Pharmacy Teaching and Practice during COVID-19, Webinar (SEMINAR), INVITED SPEAKER , 19/10/2020 to 19/10/2020
- Treatment Adherence to tyrosine kinase inhibitors. 17th Malaysian Society of Haematology Scientific Meeting, Conference (CONFERENCE), INVITED SPEAKER , 10/09/2020 to 12/09/2020